Supplementation of diets with the black rice pigment fraction attenuates atherosclerotic plaque formation in apolipoprotein E deficient mice

Journal of Nutrition

Volumn 133, Issue 3, 2003, Pages 744-751

  Xia, Min ^a   Ling, Wen Hua ^a   Ma, Jing ^a   Kitts, David D ^b   Zawistowski, Jerzy ^b,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Forbes Medi Tech Inc   (Canada)

Author keywords

ApoE deficient mice; Atherosclerosis; Black rice pigment fraction; Inflammatory response; LDL oxidation

Indexed keywords

APOLIPOPROTEIN E; CD4 ANTIGEN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLANT EXTRACT; PROTEIN ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN EXPRESSION; AORTA; ARTICLE; ATHEROSCLEROSIS; BLACK RICE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FOOD INTAKE; HEART; HYPERLIPOPROTEINEMIA TYPE 3; INFLAMMATION; INHIBITION KINETICS; LIPID BLOOD LEVEL; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; OXIDATIVE STRESS; PIGMENTATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; RICE; STATISTICAL SIGNIFICANCE; WHITE RICE;

ANIMALIA;

EID: 0037371646     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/133.3.744     Document Type: Article

References (62)

1. Breslow, J. L. (1997) Cardiovascular disease burden increases, NIH funding decreases. Nat. Med. 3: 600-601.
2. Alexander, R. W. (1994) Inflammation and coronary artery disease. N. Engl. J. Med. 331: 468-469.
3. Gordon, P. A., George, J., Khamashta, M. A., Harats, D., Hughes, G. & Shoenfeld, Y. (2001) Atherosclerosis and autoimmunity. Lupus 10: 249-252.
4. Liao, D. F., Jin, Z. G., Baas, A. S., Daum, G., Gygi, S. P., Aebersold, R. & Berk, B. C. (2000) Purification and identification of secreted oxidative stress induced factors from vascular smooth muscle cells. J. Biol. Chem. 275: 189-196.
5. Ross, R. (1999) Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340: 115-126.
6. Rimm, E. B. & Stampfer, M. J. (1997) The role of antioxidants in preventive cardiology. Curr. Opin. Cardiol. 12: 188-194.
7. Massaro, M., Carluccio, M. A. & De Caterina, R. (1999) Direct vascular antiatherogenic effects of oleic acid: a clue to the cardioprotective effects of the Mediterranean diet. Cardiologia 44: 507-513.
8. Caruso, D., Berra, B., Giavarini, F., Cortesi, N., Fedeli, E. & Galli, G. (1999) Effect of virgin olive oil phenolic compounds on in vitro oxidation of human low density lipoproteins. Nutr. Metab. Cardiovasc. Dis. 9: 102-107.
9. Sugano, M. (1996) Characteristics of fats in Japanese diets and current recommendations. Lipids 31 (Suppl): S283-S286.
10. Van, den, Hoogen, P. C., Feskens, E. J., Nagelkerke, N. J., Menotti, A., Nissinen, A. & Wiseman, H. (1999) The bioavailability of non-nutrient plant factors: dietary flavonoids and phytooestrogens. Proc. Nutr. Soc. 58: 139-146.
11. Akerblom, H. K., Viikari, J., Raitakari, O. T. & Uhari, M. (1991) Cardiovascular Risk in Young Finns Study: general outline and recent developments. Ann. Med. 31 (suppl. 1): 45-54.
12. Genest, J. (1986) Nutritional management of hypertension: past, present, and future. Can. J. Physiol. Pharmacol. 64: 836-839.
13. Kempner, W. (1946) Some effects of the rice diet treatment of kidney disease and hypertension. Bull. N. Y. Acad. Med. 22: 350-370.
14. Ling, W. H., Cheng, Q. X., Ma, J. & Wang, T. (2001) Red and black rice decrease atherosclerotic plaque formation and increase antioxidant status in rabbits. J. Nutr. 131: 1421-1426.
15. Ling, W. H., Wang, L. L. & Ma, J. (2002) Supplementation of the black rice outer fraction to rabbits decreases atherosclerotic plaque formation and increases antioxidant status. J. Nutr. 132: 20-26.
16. Breslow, J. L., Plump, A. & Dammerman, M. (1996) New mouse models of lipoprotein disorders and atherosclerosis. In: Atherosclerosis and Coronary Artery Disease (Fruster, V., Ross, R. & Topop, E. J., eds.), pp. 363-377. Lippincott-Raven, Philadelphia.
17. Zhang, S. H., Reddick, R. L., Piedrahita, J. A. & Maeda, N. (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science (Washington, D.C.). 258: 468-471.
18. Reeves, P. G., Nielsen, F. H. & Fahey, G. C. (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet. J. Nutr. 123: 1939-1951.
19. Paigen, B., Morrow, A., Holmes, P. A., Mitchell, D. & Williams, R. A. (1987) Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68: 231-240.
20. Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W. & Fu, P. C, (1974) Enzymatic determination of total serum cholesterol. Clin. Chem. 20: 740-745.
21. Yu, H. H., Ginsburg, G. S., Harris, N. & Rifai, N. (1997) Evaluation and clinical application of a direct low-density lipoprotein cholesterol assay in normolipidemic and hyperlipidemic adults. Am. J. Cardiol. 80: 1295-1299.
22. Shu, Y., Zhao, J. H., Zhang, M. Y., Xiao, L. J., Zhu, H., Fu, M. D. & Chen, N. S, (1999) Changes of lipids metabolism during gallstone formation in rabbit model and the effects on these changes by high density lipoprotein preparation injection. West. China Med. Univ. Acad. J. (in Chinese) 30: 64-67.
23. Folch, J., Lees, M. & Sloane Stanley, G. H. (1957) A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
24. Gamble, W., Vaughan, M., Kruth, H. S. & Avigan, J. (1978) Procedure for determination of free cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J. Lipid Res. 19: 1068-1070.
25. Shaish, A., George, J., Giburd, B., Keren, P., Levkovitz, H. & Harats, D. (1999) Dietary β-carotene and α-tocopherol combination does not inhibit atherogenesis in an apoE-deficient mouse model. Arterioscler. Thromb. Vasc. Biol. 19: 1470-1475.
26. Tsai, S. H., Lin-Shiau, S. Y. & Lin, J. K. (1999) Suppression of nitric oxide synthase and the downregulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol. 126: 673-680.
27. Buttery, L. D. Springall, D. R., Chester, A. H., Evans, T. J., Standfield, E. N., Parums, D. V., Yacoub, M. H. & Polak, J. M. (1996) Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab. Invest. 75: 77-85.
28. Colle, J. H., Falanga, P. B., Singer, M., Hevin, B. & Milon, G. (1997) Quantitation of messenger RNA by competitive RT-PCR: a simplified read out assay. J. Immunol. Methods 210: 175-184.
29. Davignon, J., Cohn, J. S., Mabile, L. & Bernier, L. (1999) Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin. Chim. Acta 286: 115-143.
30. Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setala, K., Walsh, A., Verstuyft, J. G., Rubin, E. M. & Breslow, J. L. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353.
31. Stein, O. & Stein, Y. (1999) Atheroprotective mechanisms of HDL. Atherosclerosis 144: 285-301.
32. McNamara, D. J. & Howell, W. H. (1992) Epidemiological data linking diet to hyperlipidemia and arteriosclerosis. Semin. Liver Dis. 124: 347-355.
33. Anthony, M. S., Clarkson, T. B. & Williams, J. K. (1998) Effects of soy isoflavones on atherosclerosis: potential mechaniam. Am. J. Clin. Nutr. 68 (Suppl): 1390S-1393S.
34. Kirk, E. A., Sutherland, P., Wanf, S. A., Chalt, A. & LeBoeuf, R. C. (1998) Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice not LDL receptor-deficient mice. J. Nutr. 128: 954-959.
35. Mironova, M., Lopes-Virella, M. F. & Virella, G. (1996) Isolation and characterization of human anti-oxidized LDL autoantibodies. Arterioscler. Thromb. Vasc. Biol. 16: 222-229.
36. Szondy, E., Lengyel, E., Mezey, Z., Fust, G. & Gero, S. (1985) Occurrence of anti-low density lipoprotein antibodies and circulating immune complexes in aged subjects. Mech. Ageing Dev. 29: 117-123.
37. Salonen, J. T., Yla-Herttuala, S., Yamamoto, R., Butter, S., Korpela, H., Salonen, R., Nyyssonen, K., Palinski, W. & Witztum, J. (1992) Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 339: 883-887.
38. Witztum, J. L. & Palinski, W. (1996) Autoimmunity to oxidized lipoproteins. In: Immune Functions of the Vessel Wall (Hansson, G. K. & Libby, P., eds.), pp. 159-172. Harwood Academic Publishers, Amsterdam, the Netherlands.
39. Palinski, W., Rosenfeld, M. E., Yla-Herttuala, S., Gurtner, G. C., Socher, S. A., Butler, S., Parthasarathy, S., Carew, T. E., Steinberg, D. & Witztum, J. L. (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. U. S. A. 86: 1372-1376.
40. Witztum, J. L. (1994) The oxidation hypothesis of atherosclerosis. Lancet 344: 793-795.
41. Steinbrecher, U. P., Fisher, M., Witztum, J. L. & Curtiss, L. K. (1984) Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation or carbamylation: generation of antibodies specific for derivatized lysine. J. Lipid Res. 25: 1109-1116.
42. Palinski, W., Yla-Herttuala, S., Rosenfeld, M. E., Butler, S., Socher, S. A., Parthasarathy, S., Curtiss, L. K. & Witztum, J. L. (1990) Antisera and monoclonal antibodies specific for epitopes generated during the oxidative modification of low density lipoprotein. Arteriosclerosis 10: 325-335.
43. Palinski, W., Miller, E. & Witztum, J. L. (1995) Immunization of low density lipoprotein (LDL) deficient rabbits with homologous malondialdehyde modified LDL reduces atherogenesis. Proc. Natl. Acad. Sci. U. S. A. 92: 821-825.
44. + T cells infiltrate lesions of apolipoprotein E-deficient mice. Am. J. Pathol. 149: 359-366.
45. Hansson, G. K., Holm, J. & Jonasson, L. (1989) Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135: 169-175
46. Geng, Y. L., Holm, J., Nygren, S., Bruzelius, M., Stemme, S. & Hansson G. (1995) Expression of the macrophage scavenger receptor in atheroma: relation to immune activation and the T cell cytokine, interferon-γ. Arterioscler Thromb. Vasc. Biol. 15: 1995-2002.
47. Pober, J. S., Gimbrone, M. A., Jr., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R. & Springer, T. A. (1986) Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137: 1893-1896.
48. Knowles, R. G. & Moncada, S. (1995) Nitric oxide synthase in mammals. Biochem. J. 298: 249-258.
49. Loscalzo, J. & Welch, G. (1995) Nitric oxide and its role in the cardiovascular system. Prog. Cardiovasc. Dis. 38: 87-104.
50. Aviram, M., Dorenfeld, L., Rosenblat, M., Volkova, N., Kaplan, M., Coleman, R., Hayek, T., Presser, D. & Fuhrman, B. (2000) Pomegranate juice consumption reduces oxidative stress, low density lipoprotein modifications and platelet aggregation: studies in the atherosclerotic apolipoprotein E deficient mice and in humans. Am. J. Clin. Nutr. 71: 1062-1076.
51. Fuhrman, B. & Aviram, M. (2002) Preservation of paraoxonase activity by wine. Flavonoids possible role in protection of LDL from lipid peroxidation. Ann. N. Y. Acad. Sci. 957: 321-324.
52. Hayek, T., Fuhrman, B., J. Vaya, Rosenblat, M., Belinky, P., Coleman, R., Elis, A. & Aviram, M. (1997) Reduced progression of atherosclerosis in the apolipoprotein E deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol. 17: 2744-2752.
53. Wu, K. K. (1995) Inducible cyclooxygenase and nitric oxide synthase. Adv. Pharmacol. 33: 179-207.
54. Nathan, C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J. 6: 3051-3064.
55. Crow, J. P. & Beckman, J. S. (1995) Reactions between nitric oxide, superoxide, and peroxynitrite: footprints of peroxynitrite in vivo. Adv. Pharmacol. 34: 17-43.
56. MacMicking, J., Xie, Q. W. & Nathan, C. (1997) Nitric oxide and macrophage function. Annu. Rev. Immunol. 15: 323-350.
57. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A. & Freeman, B.A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87: 1620-1624.
58. Hu, C., Kitts, D. D. & Zawistowski, J. (2001) Anthocyanins: bioactivity and potential uses in functional foods. In International Conference and Exhibition on Nutraceuticals and Functional Foods, December, Portland, OR.
59. Kondo, K., Kurihara, M., Miyata, N., Suzuki, T. & Toyoda, M. (1999) Mechanistic studies of catechins as antioxidants against radical oxidation. Arch. Biochem. Biophys. 363: 79-86.
60. Rice-Evans, C. (2001) Flavonoid antioxidants, Curr. Med. Chem. 8: 797-807.
61. Cheon, B, S., Kim, Y. H., Son, K. S., Chang, H. W., Kang, S. S. & Kim, H. P. (2000) Effects of prenylated flavonoids and biflavonoids on lipopolysaccharide-induced nitric oxide production from the mouse macrophage cell line RAW 264.7. Plant. Med. 66: 596-600.
62. Kim, H. K., Cheon, B. S., Kim, Y. H., Kim, S. Y. & Kim, H. P. (1999) Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem. Pharmacol. 58: 759-765.